Its compounding status has been unsettled and repeatedly revised: the FDA placed ipamorelin (with CJC-1295) on the Category 2 "do not compound" bulks list in October 2023 citing insufficient safety data
That later meeting is expected to address: Cathelicidin, also known as LL-37 GHK-Cu Dihexa acetate Melanotan II Pegylated mechano growth factor, also known as PEG-MGF FDA has not yet posted the final date and time for that meeting
The starting dose of 0.3 mg represents approximately 6.7% of the final maintenance dosea conservative approach that prioritizes safety
What are other purported benefits of these peptides, and how are they being used
It promotes angiogenesis (the formation of new blood vessels), boosts collagen production, and reduces inflammation
Critically, the review documented TB4s ability to decrease the number of myofibroblasts in wounds, resulting in decreased scar formation and fibrosis a property that directly complements BPC-157s pro-collagen activity in the Wolverine Stack combination